Skip to Content

93 1026 (Nefazodone 250 mg)

Pill imprint 93 1026 has been identified as Nefazodone hydrochloride 250 mg.

Nefazodone is used in the treatment of major depressive disorder; anxiety; depression; panic disorder and belongs to the drug class phenylpiperazine antidepressants. Risk cannot be ruled out during pregnancy. Nefazodone 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Nefazodone hydrochloride 250 mg 93 1026 Front
Nefazodone hydrochloride 250 mg 93 1026 Back
Nefazodone hydrochloride 250 mg 93 1026 Front
Nefazodone hydrochloride 250 mg 93 1026 Back
Nefazodone hydrochloride 250 mg 93 1026
Nefazodone hydrochloride 250 mg 93 1026
Nefazodone hydrochloride
Imprint:
93 1026
Strength:
250 mg
Color:
White
Size:
16.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Phenylpiperazine antidepressants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00093-1026
Inactive Ingredients:
silicon dioxide
magnesium stearate
microcrystalline cellulose
sodium starch glycolate type A potato
povidone
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
42291-0627 AvKare, Inc.
21695-0177 Rebel Distributors Corp (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide